Super enhancer-driven core transcriptional regulatory circuitry crosstalk with cancer plasticity and patient mortality in triple-negative breast cancer

• Published in: Frontiers in genetics Vol. 14; p. 1258862
• Main Authors: Shi, Wensheng, Zhong, Bowen, Dong, Jiaming, Hu, Xiheng, Li, Lingfang
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 12-10-2023
• Subjects: cancer plasticity; core transcriptional regulatory circuitry; Genetics; patient mortality; super enhancer; triple-negative breast cancer
• ISSN: 1664-8021; 1664-8021
• DOI: 10.3389/fgene.2023.1258862

Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer. Core transcriptional regulatory circuitry (CRC) consists of autoregulated transcription factors (TFs) and their enhancers, which dominate gene expression programs and control cell fate. However, there is limited knowledge of CRC in TNBC. Herein, we systemically characterized the activated super-enhancers (SEs) and interrogated 14 CRCs in breast cancer. We found that CRCs could be broadly involved in DNA conformation change, metabolism process, and signaling response affecting the gene expression reprogramming. Furthermore, these CRC TFs are capable of coordinating with partner TFs bridging the enhancer-promoter loops. Notably, the CRC TF and partner pairs show remarkable specificity for molecular subtypes of breast cancer, especially in TNBC. USF1, SOX4, and MYBL2 were identified as the TNBC-specific CRC TFs. We further demonstrated that USF1 was a TNBC immunophenotype-related TF. Our findings that the rewiring of enhancer-driven CRCs was related to cancer immune and mortality, will facilitate the development of epigenetic anti-cancer treatment strategies.